10-Q Filing

Xenetic Biosciences, Inc. CIK: 1534525 Q1 2014

Filing Information

Form Type	10-Q
Accession Number	`0001193125-14-206613`
Period End Date	20140331
Filing Date	20140520
Fiscal Year	2014
Fiscal Period	Q1
XBRL Instance	xbio-20140331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 34 Cash Flow Statement 40

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	215.46M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	215.46M	shares	Point-in-time
Cash	`Cash`	$4.84M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	130.58M	shares	Point-in-time
Cash	`Cash`	$11.14M	USD	Point-in-time
Cash	`Cash`	$9.54M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	146.74M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	136.05M	shares	Point-in-time
Cash	`Cash`	$10.86M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$66.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	119.89M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	136.05M	shares	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$66.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	136.05M	shares	Point-in-time
Other receivables	`AccountsAndOtherReceivablesNetCurrent`	$245.74K	USD	Point-in-time
Other receivables	`AccountsAndOtherReceivablesNetCurrent`	$256.01K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$329.36K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$168.31K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.33M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$11.50M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$148.81K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$152.60K	USD	Point-in-time
Goodwill	`Goodwill`	$3.67M	USD	Point-in-time
Goodwill	`Goodwill`	$3.59M	USD	Point-in-time
Goodwill	`Goodwill`	$3.70M	USD	Point-in-time
Goodwill	`Goodwill`	$4.13M	USD	Point-in-time
Indefinite-lived intangible assets	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$10.41M	USD	Point-in-time
Indefinite-lived intangible assets	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$10.32M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$112.93K	USD	Point-in-time
Total assets	`Assets`	$19.47M	USD	Point-in-time
Total assets	`Assets`	$25.87M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$592.38K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$942.16K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.09M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.83M	USD	Point-in-time
Accrued payroll taxes	`AccruedPayrollTaxesCurrent`	$299.46K	USD	Point-in-time
Accrued payroll taxes	`AccruedPayrollTaxesCurrent`	$84.60K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$55.27K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$34.36K	USD	Point-in-time
Loans due to related parties	`DueToRelatedPartiesCurrent`	$681.12K	USD	Point-in-time
Loans due to related parties	`DueToRelatedPartiesCurrent`	$681.04K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.70M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.59M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$3.26M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$3.29M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$70.61K	USD	Point-in-time
Total liabilities	`Liabilities`	$6.85M	USD	Point-in-time
Total liabilities	`Liabilities`	$6.06M	USD	Point-in-time
Commitments and contingent liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingent liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.01 par value; 215,456,000 shares authorized as of March 31, 2014 and December 31, 2013; 146,740,692 and 130,575,516 shares issued as of March 31, 2014 and December 31, 2013, respectively; 136,052,498 and 119,887,322 shares outstanding as of March 31, 2014 and December 31, 2013, respectively	`CommonStockValue`	$1.47M	USD	Point-in-time
Common stock, $0.01 par value; 215,456,000 shares authorized as of March 31, 2014 and December 31, 2013; 146,740,692 and 130,575,516 shares issued as of March 31, 2014 and December 31, 2013, respectively; 136,052,498 and 119,887,322 shares outstanding as of March 31, 2014 and December 31, 2013, respectively	`CommonStockValue`	$1.31M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$87.98M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$74.00M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-58.31M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-65.38M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$900.25K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.03M	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$12.62M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$19.81M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$25.87M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$19.47M	USD	Point-in-time

Income Statement 34 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	1 Quarter
Cost of revenue	`CostOfRevenue`	-	USD	1 Quarter
Cost of revenue	`CostOfRevenue`	-	USD	1 Quarter
Gross profit	`GrossProfit`	-	USD	1 Quarter
Gross profit	`GrossProfit`	-	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$622.11K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$565.90K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.43M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$764.22K	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$1.39M	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$2.99M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-2.99M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.39M	USD	1 Quarter
Loss on disposal of subsidiaries	`GainLossOnSaleOfBusiness`	$-1.07M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$10.72K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$1.04K	USD	1 Quarter
Interest expense	`InterestExpense`	$884.00	USD	1 Quarter
Total other income (expense)	`OtherNonoperatingIncomeExpense`	$-1.07M	USD	1 Quarter
Total other income (expense)	`OtherNonoperatingIncomeExpense`	$10.72K	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.38M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-4.06M	USD	1 Quarter
Income tax	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Net loss	`ProfitLoss`	$-4.06M	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.38M	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$125.88K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.22M	USD	1 Quarter
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-2.60M	USD	1 Quarter
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.94M	USD	1 Quarter
Net loss per share of common stock, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Net loss per share of common stock, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	1 Quarter
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	119.83M	shares	1 Quarter
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	136.05M	shares	1 Quarter

Cash Flow Statement 40 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-4.06M	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.38M	USD	1 Quarter
Depreciation	`Depreciation`	$15.99K	USD	1 Quarter
Depreciation	`Depreciation`	$15.66K	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$105.08K	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$388.93K	USD	1 Quarter
Loss on disposal of subsidiaries	`GainLossOnSaleOfBusiness`	$-1.07M	USD	1 Quarter
Foreign currency translation	`ForeignCurrencyTransactionGainLossBeforeTax`	$6.11K	USD	1 Quarter
Foreign currency translation	`ForeignCurrencyTransactionGainLossBeforeTax`	$-41.97K	USD	1 Quarter
Accounts receivable, prepayments and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-125.19K	USD	1 Quarter
Accounts receivable, prepayments and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$258.58K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-840.83K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$145.43K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-3.69M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-942.28K	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.09K	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$16.99K	USD	1 Quarter
Sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$5.50K	USD	1 Quarter
Cash acquired from Acquisition	`CashAcquiredFromAcquisition`	$43.50K	USD	1 Quarter
Cash transferred in connection with Hive Out Agreement	`CashDivestedFromDeconsolidation`	$43.50K	USD	1 Quarter
Fee paid in connection with Hive Out Agreement	`BusinessCombinationTransactionFeesPaid`	$430.00K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-441.49K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-4.09K	USD	1 Quarter
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$10.00M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$101.93K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$10.10M	USD	1 Quarter
Effect of exchange rate change on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$51.85K	USD	1 Quarter
Effect of exchange rate change on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-655.37K	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents, excluding restricted cash	`CashPeriodIncreaseDecrease`	$6.02M	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents, excluding restricted cash	`CashPeriodIncreaseDecrease`	$-1.60M	USD	1 Quarter
Cash and cash equivalents at beginning of period	`Cash`	$4.84M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`Cash`	$11.14M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`Cash`	$9.54M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`Cash`	$10.86M	USD	Point-in-time
Cash and cash equivalents at end of period	`Cash`	$4.84M	USD	Point-in-time
Cash and cash equivalents at end of period	`Cash`	$11.14M	USD	Point-in-time
Cash and cash equivalents at end of period	`Cash`	$9.54M	USD	Point-in-time
Cash and cash equivalents at end of period	`Cash`	$10.86M	USD	Point-in-time
Equity consideration transferred in the Acquisition	`BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable`	$3.75M	USD	1 Quarter
Repurchase and cancellation of common stock in the Hive Out Agreement	`PaymentsForRepurchaseAndCancellationOfCommonStock`	$3.11M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.